Compare FRMM & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRMM | DRIO |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.7M | 70.6M |
| IPO Year | 2017 | 2013 |
| Metric | FRMM | DRIO |
|---|---|---|
| Price | $4.92 | $6.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 95.4K | 14.9K |
| Earning Date | 05-26-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | $6,547,000.00 | ★ $7,394,000.00 |
| Revenue This Year | $183.55 | $20.27 |
| Revenue Next Year | $166.48 | $47.58 |
| P/E Ratio | ★ N/A | $3.83 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $1.76 | $5.84 |
| 52 Week High | $7.15 | $17.74 |
| Indicator | FRMM | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 43.14 |
| Support Level | $4.31 | $6.49 |
| Resistance Level | $5.18 | $8.10 |
| Average True Range (ATR) | 0.24 | 0.25 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 59.34 | 11.94 |
Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.